Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Up 8.3 % Shares of PIRS opened at $0.17 on Friday. The company’s fifty day simple moving average is $0.17 and its 200-day […]

Related Keywords

,Institutional Trading Of Pieris Pharmaceuticals ,News Ratings For Pieris Pharmaceuticals Daily ,Pieris Pharmaceuticals Inc ,Pieris Pharmaceuticals Trading ,Topco Ltd ,Hsbc Holdings ,Oppenheimer Co ,Pieris Pharmaceuticals ,Mirabella Financial Services ,Tower Research Capital ,Free Report ,Financial Services ,Research Capital ,Get Free Report ,Pieris Pharmaceuticals Daily ,Nasdaq Pirs ,Dpirs ,Medical ,Initiated Coverage ,Stocknews Com ,